Hiroyuki Baba

Hiroyuki Baba

General Counsel at SUMITOMO PHARMA CO., LTD.

Health Technology

Hiroyuki Baba active positions

Companies	Position	Start	End
SUMITOMO PHARMA CO., LTD.	General Counsel	2022-03-31	-
SUMITOMO PHARMA CO., LTD.	Director/Board Member	2022-03-31	2024-06-24
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA.	Director/Board Member	2021-12-31	-
	Corporate Officer/Principal	2021-12-31	-

Career history of Hiroyuki Baba

Statistics

International

Japan	2
United States	2

Operational

Director/Board Member	2
General Counsel	1
Corporate Officer/Principal	1

Sectoral

Health Technology

3

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies	1
SUMITOMO PHARMA CO., LTD.	Health Technology

Private companies

1

Health Technology

See company connections

Protect and grow your investments with the help of our experts

Secure my Investments

fermer